Exercise for women with lymphoedema

Recruiting

• Conditions: Women with unilateral upper limb lymphoedema following breast cancer surgery; Cancer - Breast

• Registration Number: ACTRN12606000435583
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-10-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Have had unilateral surgery for breast cancer* have completed treatment for breast cancer at least 6 months ago* have unilateral upper limb lymphoedema* have had lymphoedema present for at least 6 months* finished treatment for lymphoedema at least 1 month ago* are willing to attend training and follow-up sessions* are willing to be randomised into either treatment group.* are able to understand written and spoken english.

Exclusion Criteria

Have metastatic cancer* have a pacemaker or other inbuilt stimulator* are pregnant* have a previous fracture, undergpne surgery in the upper limbs or suffer any neurological deficit or other injury to either upper limb that may interfere with test procedures.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in upper limb composition. Multi frequency bio-impedance (MFBIA) will be used to identify changes in tissue density, and in particular, extracellular fluid. In addition, measures of limb volume will be undertaken using a perometer and arm circumference measures with a tape measure.[At baseline, 10 weeks (or following the completion of training) and 6 months following the completion of training]

Secondary Outcome Measures

Name	Time	Method
1. Maximal isometric shoulder strength will be measured objectively using a standardised protocol.[Measures will be taken at baseline, 10 weeks (or following the completion of training) and 6 months following the completion of training.];2. Quality of Life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Version 3 (QLQ-C30), a 30 item survey specific to cancer patients in conjunction with Breast Module (BR23), a 23 item survey specific to women with breast cancer.[Measures will be taken at baseline, 10 weeks (or following the completion of training) and 6 months following the completion of training.]